NR2C2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.85909954097951E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.53870000033585E-07 |
Normal-vs-Stage2 |
3.70240000000521E-05 |
Normal-vs-Stage3 |
1.96265226293235E-12 |
Normal-vs-Stage4 |
4.70769978555552E-10 |
Stage1-vs-Stage2 |
5.508600E-01 |
Stage1-vs-Stage3 |
1.878170E-03 |
Stage1-vs-Stage4 |
9.638500E-03 |
Stage2-vs-Stage3 |
1.081640E-01 |
Stage2-vs-Stage4 |
1.681800E-01 |
Stage3-vs-Stage4 |
9.549800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.7245983247326E-11 |
Normal-vs-AfricanAmerican |
2.393200E-04 |
Normal-vs-Asian |
9.550200E-01 |
Caucasian-vs-AfricanAmerican |
6.952000E-01 |
Caucasian-vs-Asian |
2.066200E-02 |
AfricanAmerican-vs-Asian |
1.139050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.12789996734131E-09 |
Normal-vs-Female |
9.49839984443202E-10 |
Male-vs-Female |
7.808800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.010900E-04 |
Normal-vs-Age(41-60Yrs) |
1.25180000032366E-07 |
Normal-vs-Age(61-80Yrs) |
1.27529986571062E-10 |
Normal-vs-Age(81-100Yrs) |
2.83019999991474E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.206000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.479200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.080360E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.175790E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.658000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.338000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.009000E-01 |
Normal-vs-Grade 2 |
4.76410000005423E-06 |
Normal-vs-Grade 3 |
1.66078262253677E-12 |
Normal-vs-Grade 4 |
5.9283999931381E-10 |
Grade 1-vs-Grade 2 |
5.349700E-02 |
Grade 1-vs-Grade 3 |
2.598500E-04 |
Grade 1-vs-Grade 4 |
1.121000E-03 |
Grade 2-vs-Grade 3 |
1.339530E-03 |
Grade 2-vs-Grade 4 |
6.496000E-03 |
Grade 3-vs-Grade 4 |
4.760000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.76730000528624E-08 |
Normal-vs-ccB subtype |
2.52939999945134E-07 |
ccA subtype-vs-ccB subtype |
6.202200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.23990004111619E-09 |
Normal-vs-N1 |
5.552600E-04 |
N0-vs-N1 |
5.297400E-01 |
|
|